Hypoxia-responsive synthetic gene circuits to improve safety and potency of CAR T cell therapy for solid tumors.

Authors

null

Yannick Schreiber

Northwestern University, Evanston, IL

Yannick Schreiber , Joshua Leonard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Immunotherapies

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 37)

DOI

10.1200/JCO.2024.42.23_suppl.37

Abstract #

37

Poster Bd #

A10

Abstract Disclosures

Similar Posters

First Author: Mason Webb

Poster

2023 ASCO Annual Meeting

Selective recognition of over-expressed self-antigens in solid tumors using calibrated CAR-T therapy.

Selective recognition of over-expressed self-antigens in solid tumors using calibrated CAR-T therapy.

First Author: Farzad Haerizadeh

First Author: Jennifer M. Ahlstrom

First Author: Catherine Michelle Albert